Track topics on Twitter Track topics that are important to you
CARA Stock: Bullish Tailwinds Cara Therapeutics Inc (NASDAQ:CARA) stock has caught my an eye for a number of reasons. The price chart is compelling and constructive, and the company is delving into...
* Cara therapeutics inc- top line data expected in 1h 2017 from three late-stage clinical programs
Joel Tune, Chief Executive Officer and Executive Chairman of Enteris BioPharma, commented, "We congratulate Cara Therapeutics on the initiation of its Phase 2b clinical Read more...
* Cara Therapeutics initiates enrollment in phase 2B trial of peripherally acting kappa opioid agonist, oral CR845, in chronic pain patients
Pin-X Chewable Tablets PINWORMTREATMENT
Orange juice is considered an excellent dietary source of several bioactive compounds with beneficial properties for human health. Citrus sinensis Osbeck cv. "Cara Cara" is a bud mutation originated f...
There is an urgent need to discover and progress anti-infectives that shorten the duration of tuberculosis (TB) treatment. Mycobacterium tuberculosis, the etiological agent of TB, is refractory to rap...
This study evaluates the effect of intake of two orange juice varieties in healthy adults. The participants will receive "Bahia" orange juice, "Cara-Cara" orange juice or a isocaloric cont...
The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...
In this study, DNA sequencing, computational biology modeling, and ex vivo drug sensitivity assays will be utilized to define clinically relevant gene mutations and identify potential ther...
The purpose of this study is to investigate a novel thermosensitive topical gel formulation for the treatment of inflammatory bowel disease (IBD), specifically ulcerative colitis.
Prospective, single-arm, open label, Safety and Performance clinical investigation.
Cara possesses both near-term clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's first patented compound, CR665, has enter...
Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...
Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...
We have published hundreds of Cara Therapeutics, Inc. news stories on BioPortfolio along with dozens of Cara Therapeutics, Inc. Clinical Trials and PubMed Articles about Cara Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cara Therapeutics, Inc. Companies in our database. You can also find out about relevant Cara Therapeutics, Inc. Drugs and Medications on this site too.